<data><id>oai:v1.datadryad.org:10255/dryad.178339</id><oai_dc:dc/dc:title>Berridge 2018 Supplementary data</oai_dc:dc/dc:title><oai_dc:dc/dc:description>Supplementary Data Berridge et al submitted to Neurology. Glutamate receptor delta2 serum antibodies in paediatric opsoclonus myoclonus ataxia syndrome. Data on proteins identified and clinical subjects who harbour autoantibodies to the protein Glutamate receptor delta2</oai_dc:dc/dc:description><oai_dc:dc/dc:subject>Autoimmune|cerebellum|encephalitis|GluD2|immunotherapy|opsoclonus myoclonus ataxia syndrome (OMAS)|neuroblastoma|paraneoplastic</oai_dc:dc/dc:subject><date
>2018-08-09T13:54:28Z</date
></data>